Bourgeon Capital Management LLC Abbott Laboratories Transaction History

Bourgeon Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$90.19 - $110.4 $180 - $220	2 Added 0.76%	266 $29,000
Q3 2023 Nov 01, 2023	BUY	$95.53 - $114.62 $95 - $114	1 Added 0.38%	264 $25,000
Q2 2023 Jul 20, 2023	BUY	$100.78 - $112.29 $100 - $112	1 Added 0.38%	263 $28,000
Q1 2023 Apr 17, 2023	BUY	$96.86 - $114.01 $96 - $114	1 Added 0.38%	262 $26,000
Q4 2022 Jan 20, 2023	BUY	$95.06 - $111.52 $190 - $223	2 Added 0.77%	261 $0
Q3 2022 Oct 27, 2022	BUY	$96.76 - $112.03 $96 - $112	1 Added 0.39%	259 $25,000
Q2 2022 Jul 27, 2022	BUY	$102.07 - $123.37 $102 - $123	1 Added 0.39%	258 $28,000
Q1 2022 May 03, 2022	BUY	$114.02 - $139.04 $29,303 - $35,733	257 New	257 $30,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Bourgeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bourgeon Capital Management LLC with notifications on news.